Compare RCKT & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKT | EVCM |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.9M | 2.1B |
| IPO Year | N/A | 2021 |
| Metric | RCKT | EVCM |
|---|---|---|
| Price | $3.21 | $12.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 8 |
| Target Price | ★ $29.12 | $11.50 |
| AVG Volume (30 Days) | ★ 2.0M | 394.6K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $718,038,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.13 |
| 52 Week Low | $2.19 | $7.66 |
| 52 Week High | $13.35 | $14.41 |
| Indicator | RCKT | EVCM |
|---|---|---|
| Relative Strength Index (RSI) | 46.08 | 60.59 |
| Support Level | $3.30 | $11.57 |
| Resistance Level | $3.57 | $14.41 |
| Average True Range (ATR) | 0.18 | 0.84 |
| MACD | -0.01 | 0.34 |
| Stochastic Oscillator | 22.81 | 58.04 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.